Clinical outcomes of nonoperative management in emphysematous urinary tract infections
- PMID: 22513034
- DOI: 10.1016/j.urology.2012.02.023
Clinical outcomes of nonoperative management in emphysematous urinary tract infections
Abstract
Objective: To investigate the clinical outcomes of nonoperative management of emphysematous urinary tract infections (EUTIs).
Methods: We retrospectively reviewed 28 consecutive cases of EUTI over a 5-year period, all of which were treated with urinary drainage and medical management without surgical intervention. EUTIs were classified as either emphysematous pyelonephritis (EP) or emphysematous cystitis (EC). Clinical, diagnostic, and therapeutic data were analyzed.
Results: Of the 28 patients evaluated, 13 had EP and 15 had EC, all of which were diagnosed by computed tomography. Of EP patients, the mean age was 54 years with a median serum creatinine (sCr) of 1.8 mg/dL (estimated glomerular filtration rate [eGFR] 38 mL/min/1.73 m(2)). Obstructive uropathy was present in 69%, and 100% received antibiotics and percutaneous drainage without mortality. Median follow-up was 10 months without any subsequent nephrectomy and median sCr decreased to 1.1 mg/dL (P = .04) and eGFR increased to 63.5 mL/min/1.73 m(2) (P = .06). Of EC patients, the mean age was 60 years with a median sCr of 1.3 mg/dL (eGFR 55 mL/min/1.73 m(2)). All were managed with antibiotics and catheter drainage with a single mortality (7%). Median follow-up was 2 months and median sCr decreased to 1.2 mg/dL (P = .83) and eGFR increased to 46 mL/min/1.73 m(2) (P = .68). The most common causative pathogen was Escherichia coli for both EP (54%) and EC (53%).
Conclusion: Early detection, medical management, and urinary drainage of EUTI can result in a favorable prognosis. This strategy results in low levels of mortality without the need for surgical intervention and can preserve renal function.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis.Arch Intern Med. 2000 Mar 27;160(6):797-805. doi: 10.1001/archinte.160.6.797. Arch Intern Med. 2000. PMID: 10737279
-
Clinical features and prognostic factors of emphysematous urinary tract infection.J Microbiol Immunol Infect. 2009 Oct;42(5):393-400. J Microbiol Immunol Infect. 2009. PMID: 20182668
-
[Results of conservative management of emphysematous pyelonephritis].Nephrol Ther. 2016 Dec;12(7):508-515. doi: 10.1016/j.nephro.2016.05.007. Epub 2016 Oct 24. Nephrol Ther. 2016. PMID: 27789323 French.
-
Complicated urinary tract infections with diabetes mellitus.J Infect Chemother. 2021 Aug;27(8):1131-1136. doi: 10.1016/j.jiac.2021.05.012. Epub 2021 May 20. J Infect Chemother. 2021. PMID: 34024733 Review.
-
Emphysematous pyelonephritis and cystitis: A case report and literature review.J Int Med Res. 2018 Jul;46(7):2954-2960. doi: 10.1177/0300060518770341. Epub 2018 Jun 19. J Int Med Res. 2018. PMID: 29916283 Free PMC article. Review.
Cited by
-
Uncommon Haemorrhagic Cystitis of Infectious Origin: A Narrative Review for Urologists.Res Rep Urol. 2023 Aug 4;15:365-373. doi: 10.2147/RRU.S412278. eCollection 2023. Res Rep Urol. 2023. PMID: 37564174 Free PMC article. Review.
-
Emphysematous Cystitis and Urinary Retention in a Male Patient With Diabetes Mellitus Type 2 Treated With Empagliflozin.AACE Clin Case Rep. 2022 Apr 8;8(4):163-165. doi: 10.1016/j.aace.2022.04.002. eCollection 2022 Jul-Aug. AACE Clin Case Rep. 2022. PMID: 35959080 Free PMC article.
-
Abdominal Pain and Fever in an Elderly Patient with Diabetes Mellitus.Kidney360. 2020 Oct 29;1(10):1180-1181. doi: 10.34067/KID.0002402020. eCollection 2020 Oct 29. Kidney360. 2020. PMID: 35368793 Free PMC article. No abstract available.
-
Emphysematous Cystitis: An Unusual Cause of Septic Shock.J Med Cases. 2022 Jan;13(1):44-46. doi: 10.14740/jmc3874. Epub 2022 Jan 17. J Med Cases. 2022. PMID: 35211236 Free PMC article.
-
A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis.Int Urol Nephrol. 2022 Apr;54(4):717-736. doi: 10.1007/s11255-022-03131-6. Epub 2022 Feb 1. Int Urol Nephrol. 2022. PMID: 35103928 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
